Demonstrating a moderate growth in the revenue year on year, the global landscape of frontotemporal disorders treatment market is slated to approach the US$ 3 billion mark in 2022.
With the severe dearth of FDA-approved drugs in the reliable treatment of frontotemporal disorders, frontotemporal disorders treatment continues to underscore the growing significance of disease...
0 Commentarios
0 Acciones
2205 Views
0 Vista previa